Steward Partners Investment Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $510K | Buy |
2,541
+75
| +3% | +$15.5K | ﹤0.01% | 1517 |
|
|
2025
Q4 | $509K | Buy |
2,466
+16
| +0.7% | +$3.2K | ﹤0.01% | 1411 |
|
|
2025
Q3 | $439K | Buy |
2,450
+786
| +47% | +$134K | ﹤0.01% | 1447 |
|
|
2025
Q2 | $269K | Sell |
1,664
-1,100
| -40% | -$175K | ﹤0.01% | 1607 |
|
|
2025
Q1 | $470K | Buy |
2,764
+34
| +1% | +$5.91K | ﹤0.01% | 1253 |
|
|
2024
Q4 | $454K | Sell |
2,730
-253
| -8% | -$43.2K | ﹤0.01% | 1209 |
|
|
2024
Q3 | $513K | Sell |
2,983
-928
| -24% | -$154K | ﹤0.01% | 1100 |
|
|
2024
Q2 | $602K | Sell |
3,911
-172
| -4% | -$25.8K | 0.01% | 985 |
|
|
2024
Q1 | $628K | Sell |
4,083
-2,056
| -33% | -$314K | 0.01% | 963 |
|
|
2023
Q4 | $970K | Sell |
6,139
-922
| -13% | -$132K | 0.01% | 737 |
|
|
2023
Q3 | $1.03M | Sell |
7,061
-1,713
| -20% | -$261K | 0.02% | 666 |
|
|
2023
Q2 | $1.34M | Sell |
8,774
-180
| -2% | -$28.1K | 0.02% | 602 |
|
|
2023
Q1 | $1.39M | Sell |
8,954
-3,162
| -26% | -$497K | 0.02% | 575 |
|
|
2022
Q4 | $1.87M | Buy |
12,116
+258
| +2% | +$38.1K | 0.03% | 469 |
|
|
2022
Q3 | $1.56M | Buy |
11,858
+2,818
| +31% | +$395K | 0.03% | 499 |
|
|
2022
Q2 | $1.23M | Buy |
9,040
+464
| +5% | +$64K | 0.02% | 572 |
|
|
2022
Q1 | $1.28M | Sell |
8,576
-319
| -4% | -$47.2K | 0.02% | 615 |
|
|
2021
Q4 | $1.44M | Sell |
8,895
-1,590
| -15% | -$257K | 0.02% | 592 |
|
|
2021
Q3 | $1.74M | Buy |
10,485
+193
| +2% | +$33K | 0.03% | 491 |
|
|
2021
Q2 | $1.78M | Sell |
10,292
-3,177
| -24% | -$525K | 0.03% | 478 |
|
|
2021
Q1 | $2.16M | Buy |
13,469
+4,570
| +51% | +$782K | 0.04% | 414 |
|
|
2020
Q4 | $1.5M | Sell |
8,899
-145
| -2% | -$23.5K | 0.03% | 438 |
|
|
2020
Q3 | $1.42M | Buy |
9,044
+2,105
| +30% | +$344K | 0.04% | 392 |
|
|
2020
Q2 | $1.16M | Buy |
6,939
+673
| +11% | +$106K | 0.03% | 410 |
|
|
2020
Q1 | $821K | Sell |
6,266
-1,484
| -19% | -$211K | 0.03% | 431 |
|
|
2019
Q4 | $1.15M | Buy |
7,750
+898
| +13% | +$123K | 0.03% | 416 |
|
|
2019
Q3 | $848K | Sell |
6,852
-3,379
| -33% | -$450K | 0.03% | 453 |
|
|
2019
Q2 | $1.44M | Buy |
+10,231
| New | +$1.41M | 0.05% | 314 |
|
|
2019
Q1 | – | Sell |
-17,654
| Closed | -$2.19M | – | 801 |
|
|
2018
Q4 | $2.19M | Buy |
17,654
+11,606
| +192% | +$1.59M | 0.11% | 205 |
|
|
2018
Q3 | $959K | Buy |
+6,048
| New | +$915K | 0.05% | 353 |
|
|
2018
Q2 | – | Sell |
-4,025
| Closed | -$534K | – | 2472 |
|
|
2018
Q1 | $534K | Buy |
4,025
+2,995
| +291% | +$409K | 0.04% | 409 |
|
|
2017
Q4 | $128K | Buy |
1,030
+243
| +31% | +$30K | 0.01% | 601 |
|
|
2017
Q3 | $97K | Buy |
787
+163
| +26% | +$19.3K | 0.01% | 547 |
|
|
2017
Q2 | $71K | Buy |
624
+364
| +140% | +$39.1K | 0.01% | 550 |
|
|
2017
Q1 | $27K | Buy |
+260
| New | +$26.1K | ﹤0.01% | 679 |
|
Other funds holding FBT
BFG
Steward Partners Investment Advisory's FBT Position: Q1 2026 in Review
Steward Partners Investment Advisory increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 3% in Q1 2026, buying an estimated $15.5K and bringing the position to 2,541 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #1517.
Steward Partners Investment Advisory first reported a position in FBT in Q1 2017 and has held it in 35 quarters since. The position peaked at $2.19M in Q4 2018. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Steward Partners Investment Advisory held 2,541 shares of First Trust NYSE Arca Biotechnology Index Fund worth $510K as of Q1 2026.
- Steward Partners Investment Advisory bought 75 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $15.5K.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #1517 holding.
- Steward Partners Investment Advisory first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2017 and has held it in 35 quarters since.
- Steward Partners Investment Advisory's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.19M in Q4 2018.
- 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.